Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI

NCT05305911 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

81

Enrollment

OTHER

Sponsor class

Conditions

Heart Attack
Enlarged Heart

Interventions

DRUG: SGLT-2 inhibitors
DRUG: Placebo

Sponsor

Minneapolis Heart Institute Foundation